These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29062918)

  • 21. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
    European Antimicrobial Resistance Collaborators
    Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African region: A roadmap for action.
    Iwu CD; Patrick SM
    Int J Antimicrob Agents; 2021 Oct; 58(4):106411. PubMed ID: 34371112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance.
    Rogers Van Katwyk S; Danik MÉ; Pantis I; Smith R; Røttingen JA; Hoffman SJ
    Glob Health Res Policy; 2016; 1():20. PubMed ID: 29202068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review.
    van Heuvel L; Caini S; Dückers MLA; Paget J
    Global Health; 2022 Oct; 18(1):85. PubMed ID: 36253789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
    Saeed DK; Farooqi J; Shakoor S; Hasan R
    BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of whole genome sequencing in monitoring antimicrobial resistance: A biosafety and public health priority in the Arabian Peninsula.
    Alghoribi MF; Balkhy HH; Woodford N; Ellington MJ
    J Infect Public Health; 2018; 11(6):784-787. PubMed ID: 30100241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal.
    Malla S; Dumre SP; Shakya G; Kansakar P; Rai B; Hossain A; Nair GB; Albert MJ; Sack D; Baker S; Rahman M;
    BMC Public Health; 2014 Mar; 14():269. PubMed ID: 24650008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.
    Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
    Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Veepanattu P; Singh S; Mendelson M; Nampoothiri V; Edathadatil F; Surendran S; Bonaconsa C; Mbamalu O; Ahuja S; Birgand G; Tarrant C; Sevdalis N; Ahmad R; Castro-Sanchez E; Holmes A; Charani E
    Int J Infect Dis; 2020 Nov; 100():278-282. PubMed ID: 32860949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017.
    Liu C; Yoon EJ; Kim D; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Kim HS; Kim YR; Jeong SH
    J Infect Chemother; 2019 Nov; 25(11):845-859. PubMed ID: 31311694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria.
    Pezzani MD; Tornimbene B; Pessoa-Silva C; de Kraker M; Rizzardo S; Salerno ND; Harbarth S; Tacconelli E
    Clin Microbiol Infect; 2021 Jan; 27(5):687-96. PubMed ID: 33450389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.
    Allel K; Day L; Hamilton A; Lin L; Furuya-Kanamori L; Moore CE; Van Boeckel T; Laxminarayan R; Yakob L
    Lancet Planet Health; 2023 Apr; 7(4):e291-e303. PubMed ID: 37019570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance of antimicrobial resistance in human health in Tanzania: 2016-2021.
    Camara N; Moremi N; Mghamba J; Eliakimu E; Shumba E; Ondoa P; Egyir B
    Afr J Lab Med; 2023; 12(1):2053. PubMed ID: 37293314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving from assessments to implementation: promising practices for strengthening multisectoral antimicrobial resistance containment capacity.
    Joshi MP; Alombah F; Konduri N; Ndiaye A; Kusu N; Kiggundu R; Lusaya EP; Tuala Tuala R; Embrey M; Hafner T; Traore O; Mbaye M; Akinola B; Namburete D; Acho A; Hema Y; Getahun W; Sayem MA; Nfor E
    One Health Outlook; 2023 Apr; 5(1):7. PubMed ID: 37055845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of diagnostic network optimization in Kenya and Nepal to design integrated, sustainable and efficient bacteriology and antimicrobial resistance surveillance networks.
    Brunetti M; Singh A; Chebore S; Gyenwali D; Malou N; Ferreyra C; Gompo TR; Chapagain S; Githii S; Wesangula E; Albert H
    PLOS Glob Public Health; 2023; 3(12):e0002247. PubMed ID: 38055687
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.